Investigating the Impact of Advertising on Smoking Cessation: The Role of Direct-to-Consumer Prescription Drug Advertising

Published Online:https://doi.org/10.1287/mksc.2024.0848

References

  • Alpert A, Lakdawalla D, Sood N (2023) Prescription drug advertising and drug utilization: The role of Medicare Part D. J. Public Econom. 221:104860.Google Scholar
  • American Medical Association (2015) AMA calls for ban on DTC ads of prescription drugs and medical devices. Accessed February 22, 2024, https://www.ama-assn.org/press-center/press-releases/amacalls-ban-dtc-ads-prescription-drugs-and-medical-devices.Google Scholar
  • Anderson ET, Simester D (2013) Advertising in a competitive market: The role of product standards, customer learning, and switching costs. J. Marketing Res. 50(4):489–504.CrossrefGoogle Scholar
  • Aubin H-J, Bobak A, Britton JR, Oncken C, Billing CB, Gong J, Williams KE, Reeves KR (2008) Varenicline versus transdermal nicotine patch for smoking cessation: Results from a randomised open-label trial. Thorax 63(8):717–724.CrossrefGoogle Scholar
  • Avery R, Kenkel D, Lillard DR, Mathios A (2007) Private profits and public health: Does advertising of smoking cessation products encourage smokers to quit? J. Political Econom. 115(3):447–481.CrossrefGoogle Scholar
  • Basara LR (1996) The impact of a direct-to-consumer prescription medication advertising campaign on new prescription volume. Drug Inform. J. 30(3):715–729.CrossrefGoogle Scholar
  • Braun M, Moe WW (2013) Online display advertising: Modeling the effects of multiple creatives and individual impression histories. Marketing Sci. 32(5):753–767.LinkGoogle Scholar
  • Centers for Disease Control and Prevention (2023) Tobacco use. Accessed December 15, 2023, https://www.cdc.gov/chronicdisease/resources/publications/factsheets/tobacco.htm.Google Scholar
  • Centers for Disease Control and Prevention (2024a) E-cigarette use among adults. Accessed March 29, 2025, https://www.cdc.gov/tobacco/e-cigarettes/adults.html.Google Scholar
  • Centers for Disease Control and Prevention (2024b) How to use quit smoking medicines. Accessed September 7, 2024, https://www.cdc.gov/tobacco/campaign/tips/quit-smoking/quit-smoking-medications/howto-use-quit-smoking-medicines/index.html.Google Scholar
  • Chae I, Stephen AT, Bart Y, Yao D (2017) Spillover effects in seeded word-of-mouth marketing campaigns. Marketing Sci. 36(1):89–104.LinkGoogle Scholar
  • Chen J, Roth J (2024) Logs with zeros? Some problems and solutions. Quart. J. Econom. 139(2):891–936.CrossrefGoogle Scholar
  • Chintagunta PK, Vilcassim NJ (1992) An empirical investigation of advertising strategies in a dynamic duopoly. Management Sci. 38(9):1230–1244.LinkGoogle Scholar
  • Daubresse M, Hutfless S, Kim Y, Kornfield R, Qato DM, Huang J, Miller K, Emery SL, Alexander GC (2015) Effect of direct-to-consumer advertising on asthma medication sales and healthcare use. Amer. J. Respiratory Critical Care Medicine 192(1):40–46.CrossrefGoogle Scholar
  • David G, Markowitz S, Richards-Shubik S (2010) The effects of pharmaceutical marketing and promotion on adverse drug events and regulation. Amer. Econom. J. Econom. Policy 2(4):1–25.CrossrefGoogle Scholar
  • DiStefano MJ, Markell JM, Doherty CC, Alexander GC, Anderson GF (2023) Association between drug characteristics and manufacturer spending on direct-to-consumer advertising. J. Amer. Medical Assoc. 329(5):386–392.CrossrefGoogle Scholar
  • Dubé J-P, Hitsch GJ, Manchanda P (2005) An empirical model of advertising dynamics. Quant. Marketing Econom. 3(2):107–144.CrossrefGoogle Scholar
  • Dubé J-P, Hitsch GJ, Rossi PE (2018) Income and wealth effects on private-label demand: Evidence from the great recession. Marketing Sci. 37(1):22–53.LinkGoogle Scholar
  • Duggan M, Morton FS (2010) The effect of Medicare Part D on pharmaceutical prices and utilization. Amer. Econom. Rev. 100(1):590–607.CrossrefGoogle Scholar
  • Eisenberg MD, Rabideau B, Alpert AE, Avery RJ, Niederdeppe J, Sood N (2022) The impact of direct-to-consumer advertising on outpatient care utilization. NBER Working Paper No. 30791, National Bureau of Economic Research, Cambridge, MA.Google Scholar
  • Goldman DP, Joyce GF, Zheng Y (2007) Prescription drug cost sharing: Associations with medication and medical utilization and spending and health. J. Amer. Medical Assoc. 298(1):61–69.CrossrefGoogle Scholar
  • Goli A, Mummalaneni S, Chintagunta PK, Dhar SK (2022) Show and sell: Studying the effects of branded cigarette product placement in TV shows on cigarette sales. Marketing Sci. 41(6):1163–1180.LinkGoogle Scholar
  • Horsky D (1977) An empirical analysis of the optimal advertising policy. Management Sci. 23(10):1037–1049.LinkGoogle Scholar
  • Hristakeva S, Mortimer JH (2023) Price dispersion and legacy discounts in the national television advertising market. Marketing Sci. 42(6):1162–1183.LinkGoogle Scholar
  • Kim Y, Kornfield R, Shi Y, Vera L, Daubresse M, Alexander GC, Emery S (2016) Effects of televised direct-to-consumer advertising for varenicline on prescription dispensing in the United States, 2006–2009. Nicotine Tobacco Res. 18(5):1180–1187.CrossrefGoogle Scholar
  • Koegelenberg CF, Noor F, Bateman ED, van Zyl-Smit RN, Bruning A, O’Brien JA, Smith C, et al. (2014) Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: A randomized clinical trial. J. Amer. Medical Assoc. 312(2):155–161.CrossrefGoogle Scholar
  • Lawler EC, Skira MM (2022) Information shocks and pharmaceutical firms’ marketing efforts: Evidence from the Chantix black box warning removal. J. Health Econom. 81:102557.CrossrefGoogle Scholar
  • Ling DC, Berndt ER, Kyle MK (2002) Deregulating direct-to-consumer marketing of prescription drugs: Effects on prescription and over-the-counter product sales. J. Law Econom. 45(S2):691–723.CrossrefGoogle Scholar
  • Lotz AD (2007) How to spend $9.3 billion in three days: Examining the upfront buying process in the production of US television culture. Media Culture Soc. 29(4):549–567.CrossrefGoogle Scholar
  • Martin GJ, Yurukoglu A (2017) Bias in cable news: Persuasion and polarization. Amer. Econom. Rev. 107(9):2565–2599.CrossrefGoogle Scholar
  • Menkes DB, Mintzes B, Lexchin J (2023) Time for New Zealand to ban direct-to-consumer advertising of prescription medicines. New Zealand Medical J. 136(1575):7–9.CrossrefGoogle Scholar
  • Mizik N, Jacobson R (2004) Are physicians “easy marks”? Quantifying the effects of detailing and sampling on new prescriptions. Management Sci. 50(12):1704–1715.LinkGoogle Scholar
  • Narayanan S, Desiraju R, Chintagunta PK (2004) Return on investment implications for pharmaceutical promotional expenditures: The role of marketing-mix interactions. J. Marketing 68(4):90–105.CrossrefGoogle Scholar
  • Qi S (2013) The impact of advertising regulation on industry: The cigarette advertising ban of 1971. RAND J. Econom. 44(2):215–248.CrossrefGoogle Scholar
  • Rosenthal MB, Berndt ER, Donohue JM, Epstein AM, Frank RG (2003) Demand effects of recent changes in prescription drug promotion. Cutler DM, Garber AM, eds. Frontiers in Health Policy Research, vol. 6 (MIT Press, Cambridge, MA), 1–26.CrossrefGoogle Scholar
  • Rossi PE (2018) Causal inference in marketing applications. Mizik N, Hanssens D, eds. Handbook of Marketing Analytics: Methods and Applications in Marketing Management, Public Policy, and Litigation Support (Edward Elgar Publishing, Northampton, MA), 135–152.CrossrefGoogle Scholar
  • Rutz OJ, Bucklin RE (2011) From generic to branded: A model of spillover in paid search advertising. J. Marketing Res. 48(1):87–102.CrossrefGoogle Scholar
  • Saffer H, Chaloupka F (2000) The effect of tobacco advertising bans on tobacco consumption. J. Health Econom. 19(6):1117–1137.CrossrefGoogle Scholar
  • Sahni NS (2016) Advertising spillovers: Evidence from online field experiments and implications for returns on advertising. J. Marketing Res. 53(4):459–478.CrossrefGoogle Scholar
  • Shapiro BT (2018) Positive spillovers and free riding in advertising of prescription pharmaceuticals: The case of antidepressants. J. Political Econom. 126(1):381–437.CrossrefGoogle Scholar
  • Shapiro BT (2022) Promoting wellness or waste? Evidence from antidepressant advertising. Amer. Econom. J. Microeconom. 14(2):439–477.CrossrefGoogle Scholar
  • Shapiro BT, Hitsch GJ, Tuchman AE (2021) TV advertising effectiveness and profitability: Generalizable results from 288 brands. Econometrica 89(4):1855–1879.CrossrefGoogle Scholar
  • Shrestha SS, Ghimire R, Wang X, Trivers KF, Homa DM, Armour BS (2022) Cost of cigarette smoking—Attributable productivity losses, U.S., 2018. Amer. J. Preventive Medicine 63(4):478–485.CrossrefGoogle Scholar
  • Simonov A, Sacher S, Dubé J-P, Biswas S (2022) Frontiers: The persuasive effect of Fox News: Noncompliance with social distancing during the COVID-19 pandemic. Marketing Sci. 41(2):230–242.LinkGoogle Scholar
  • Stremersch S, Landsman V, Venkataraman S (2013) The relationship between DTCA, drug requests, and prescriptions: Uncovering variation in specialty and space. Marketing Sci. 32(1):89–110.LinkGoogle Scholar
  • Taylor GM, Taylor AE, Thomas KH, Jones T, Martin RM, Munafò MR, Windmeijer F, Davies NM (2017) The effectiveness of varenicline versus nicotine replacement therapy on long-term smoking cessation in primary care: A prospective cohort study of electronic medical records. Internat. J. Epidemiology 46(6):1948–1957.CrossrefGoogle Scholar
  • Tuchman AE (2019) Advertising and demand for addictive goods: The effects of e-cigarette advertising. Marketing Sci. 38(6):994–1022.AbstractGoogle Scholar
  • Tye JB, Warner KE, Glantz SA (1987) Tobacco advertising and consumption: Evidence of a causal relationship. J. Public Health Policy 8(4):492–508.CrossrefGoogle Scholar
  • U.S. Census Bureau (2021) Understanding and using the American Community Survey public use microdata sample files: What data users need to know. Accessed January 19, 2024, https://www.census.gov/content/dam/Census/library/publications/2021/acs/acs_pums_handbook_2021.pdf.Google Scholar
  • U.S. Department of Health and Human Services (2020) Smoking cessation: A report of the Surgeon General. Accessed December 20, 2023, https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf.Google Scholar
  • Wang Y, Lewis M, Singh V (2021) Investigating the effects of excise taxes, public usage restrictions, and antismoking ads across cigarette brands. J. Marketing 85(3):150–167.CrossrefGoogle Scholar
  • World Health Organization (2023) Tobacco. Accessed January 17, 2024, https://www.who.int/news-room/fact-sheets/detail/tobacco.Google Scholar
  • Wosinska M (2005) Direct-to-consumer advertising and drug therapy compliance. J. Marketing Res. 42(3):323–332.CrossrefGoogle Scholar
  • Zadeh NK, Robertson K, Green JA (2019) Lifestyle determinants of behavioural outcomes triggered by direct-to-consumer advertising of prescription medicines: A cross-sectional study. Australian New Zealand J. Public Health 43(2):190–196.CrossrefGoogle Scholar
  • Zhu S-H, Cummins SE, Gamst AC, Wong S, Ikeda T (2016) Quitting smoking before and after varenicline: A population study based on two representative samples of US smokers. Tobacco Control 25(4):464–469.CrossrefGoogle Scholar
INFORMS site uses cookies to store information on your computer. Some are essential to make our site work; Others help us improve the user experience. By using this site, you consent to the placement of these cookies. Please read our Privacy Statement to learn more.